Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Biol Reprod ; 71(5): 1746-52, 2004 Nov.
Article in English | MEDLINE | ID: mdl-15269102

ABSTRACT

Leptin is a polypeptide hormone produced by adipose and other endocrine tissues. Although it has been linked to receptor-mediated pathways that directly influence human conceptus development, mechanisms that regulate the leptin receptor in pregnancy-specific tissues remain unclear. Therefore, we assessed leptin-receptor ontogeny and regulation in the baboon (Papio sp.), a primate model for human pregnancy. Placentae, decidua, and amniochorion were collected from baboons in early (Days 54-63, n = 4), mid (Days 98-103, n = 4), and late (Days 159-165, n = 4) gestation. Regulation by estrogen was assessed by elimination of androgen precursors via removal of the fetus (fetectomy) at midgestation and collection of tissues in late gestation (n = 4; term, approximately 184 days). Maternal serum was sampled with advancing gestation, and the abundance of soluble leptin receptor (solLepR), a potential mediator of gestational hyperleptinemia, was determined. Two placental leptin-receptor isoforms (130 and 150 kDa) increased (P < 0.04 and P < 0.02, respectively) in abundance with advancing gestation. Similarly, the 130-kDa isoform increased approximately fourfold (P < 0.0025) in decidua and approximately 10-fold (P < 0.015) in amniochorion between early and late gestation. Following fetectomy, maternal serum estradiol levels declined approximately 85% (P < 0.03), and the 150-kDa placental leptin-receptor isoform was reduced by more than half (P < 0.002). Maternal serum solLepR concentrations were correlated with gestational age (r = 0.52, P < 0.01) and were unaffected by fetectomy. The presence of leptin-receptor isoforms in pregnancy-specific tissues further denoted leptin's potential to directly influence conceptus development, whereas the 130-kDa solLepR identified in maternal serum suggested a means to facilitate the hyperleptinemia typical of primate pregnancy. Although estrogen did not appear to be the principal regulator of solLepR, it and other factors linked to advancing gestation may be implicated in the regulation of leptin-receptor synthesis.


Subject(s)
Gestational Age , Papio/metabolism , Pregnancy, Animal/metabolism , Receptors, Cell Surface/chemistry , Receptors, Cell Surface/metabolism , Animals , Biological Availability , Estrogens/blood , Female , Papio/blood , Pregnancy , Pregnancy, Animal/blood , Protein Isoforms/metabolism , Receptors, Cell Surface/biosynthesis , Receptors, Cell Surface/blood , Receptors, Leptin , Solubility
2.
Biol Reprod ; 67(1): 178-83, 2002 Jul.
Article in English | MEDLINE | ID: mdl-12080015

ABSTRACT

We previously suggested that cadmium (Cd), an environmental toxicant and constituent of tobacco smoke, inhibits progesterone secretion in cultured human placental trophoblasts by inhibiting low-density lipoprotein receptor mRNA expression. In the current study, we investigated whether Cd also disrupts progesterone synthesis via P450 cholesterol side-chain cleavage (P450(scc)) and 3beta-hydroxysteroid dehydrogenase (3beta-HSD), enzymes that play important roles in placental steroidogenesis. Human cytotrophoblasts were purified by density gradient centrifugation and incubated in Dulbecco modified Eagle medium + 10% fetal bovine serum with 0, 5, 10, or 20 microM CdCl(2) for 96 h. Cells progressed to syncytiotrophoblastic maturity regardless of treatment. No differences (P > 0.05) in cell protein and lactate dehydrogenase activity were observed between untreated trophoblasts and those treated with CdCl(2). However, P450(scc) and 3beta-HSD mRNA transcript levels declined in a dose-dependent manner (P <0.05) in trophoblasts cocultured with 5, 10, or 20 microM CdCl(2). P450(scc) activity was similarly inhibited (P < 0.05) by CdCl(2) treatment, although 3beta-HSD activity was not significantly affected. Coculture with 8-bromo-cAMP enhanced progesterone secretion in untreated cultures but did not reverse the decline in progesterone secretion induced by CdCl(2) treatment. CdCl(2) failed to influence cAMP content in cultured cells. Collectively, results suggest that P450(scc) enzyme is another site at which Cd interferes with placental progesterone production. However, it is unlikely that an inhibition of cAMP is involved with the inhibition of progesterone biosynthesis by Cd in human trophoblasts.


Subject(s)
3-Hydroxysteroid Dehydrogenases/metabolism , Cadmium/toxicity , Cholesterol Side-Chain Cleavage Enzyme/metabolism , Endocrine Glands/physiology , Placenta/physiology , Trophoblasts/physiology , 3-Hydroxysteroid Dehydrogenases/antagonists & inhibitors , 8-Bromo Cyclic Adenosine Monophosphate/pharmacology , Aminoglutethimide/pharmacology , Cell Survival/drug effects , Cells, Cultured , Cholesterol Side-Chain Cleavage Enzyme/antagonists & inhibitors , Cyclic AMP/metabolism , DNA, Complementary/biosynthesis , Endocrine Glands/drug effects , Endocrine Glands/enzymology , Enzyme Inhibitors/pharmacology , Female , Humans , L-Lactate Dehydrogenase/metabolism , Placenta/drug effects , Placenta/enzymology , Pregnancy , Progesterone/metabolism , RNA, Messenger/biosynthesis , Reverse Transcriptase Polymerase Chain Reaction , Trophoblasts/enzymology
SELECTION OF CITATIONS
SEARCH DETAIL
...